Eliquis Lawyers: Protecting Patients In The Fight For Justice

As medical professionals watch helplessly, patients on the new blood thinner Eliquis have suffered debilitating “bleeds.” Like Pradaxa and Xaralta before it, the supposedly “groundbreaking” drug was approved without an antidote, leaving patients, families and even physicians no way to stem a life-threatening hemorrhage.

For many experts, Eliquis’ risks seem too high beside the proven benefits and relative safety of conventional anticoagulants like warfarin. In a series of new Eliquis lawsuits, Plaintiffs have gone so far as to accuse the companies behind the drug of marketing a product that, without a reversal agent, is defective in design.

After Suffering Irreversible Bleeds, Patients File Eliquis Lawsuits

Hailed as a “revolutionary” new treatment for patients with blood clots, Eliquis has now been linked to serious side effects, including a risk for potentially-fatal bleeding. While all anti-coagulants present this danger in some respect, older established drugs come with effective reversal agents.

In emergency situations, and prior to surgery, these “antidotes” are often a patient’s only hope of survival.

But Eliquis was released without a reversal agent. Like Pradaxa and Xarelto, two other new generation blood thinners, Eliquis’ effects can’t be stopped. Now patients have begun to file lawsuits, saying the drug’s manufacturers hid troves of damning safety data from the US Food & Drug Administration.

Have Any Eliquis Claims Been Filed Yet?


Several Eliquis lawsuits have already been filed, and the manufacturers of other innovative anticoagulants have been mired in legal battles for years.

Around 1,700 legal claims have already been filed for bleeding incidents linked to Xarelto, and the litigation has even been fast-tracked through the federal court system. Boehringer Ingelheim, the German company behind Pradaxa, just settled more than 4,000 bleeding lawsuits for $650 million.

Only time will tell if lawsuits involving Eliquis come to a similar result, but these recent victories for public health should give hope to patients who have suffered their own severe injuries.

Eliquis Safety Trials Tainted By Errors, Possible Fraud

Scientist performing researchManufactured by Pfizer and Bristol-Myers Squibb, Eliquis was first approved in 2012 to prevent stroke in patients at risk of systemic embolism. Approval for deep vein thrombosis came in 2014, and patients with pulmonary embolism would soon be receiving Eliquis, too.

But well before patients began experiencing severe side effects, Eliquis was already at the center of a controversy. The drug’s approval was based on two clinical trials. One, completed in 2011 and titled ARISTOTLE, concluded with results so positive the medical community seemed euphoric:

“[Eliquis is] superior to warfarin in preventing stroke or systemic embolism, cause[s] less bleeding, and result[s] in lower mortality.”

Physicians across the country had finally found their holy grail, a blood thinner better in every way than traditional therapies. But it took the FDA another nine months to approve Eliquis, and for years after, public health advocates would have no idea why. Now we do.

ARISTOTLE, a study out-sourced to China, was riddled with inaccuracies, mistakes and outright fraudulent reporting. The trial proving that Eliquis was more beneficial and less risky than warfarin was improperly conducted, a clear example of “fraud” in the words of FDA documents obtained by Pharmaceutical Approvals Monthly.

These revelations, which call Eliquis’ safety into serious doubt, are at the core of the bleeding lawsuits already filed. Each claim accuses Pfizer and Bristol-Myers Squibb of failing to adequately test the anticoagulant – and then releasing it without an antidote.

Can I File A Bleeding Lawsuit?

Until conducting a thorough evaluation of your situation, we can’t answer that question. But it’s quite possible. If you or a loved one suffered a severe bleeding incident while taking Eliquis, you may be entitled to significant financial compensation.

Without an experienced advocate, both patients and survivors can be left with no option but shoulder exorbitant medical costs and emotional trauma on their own.

Tragically, many of the first Eliquis lawsuits have claimed damages suffered after a loved one’s death. These “wrongful death” claims provide widows and widowers with substantial support financially, while helping prepare the path for emotional recovery.

Why Should I Choose The Eliquis Lawyers At Blood Thinner Help?

We believe experience should be your guide in selecting legal counsel.

BloodThinnerHelp.com is sponsored by the attorneys at Osborne & Associates Over almost four decades of experience, our trial lawyers have proved their dedication to patient rights year after year. We’ve secured more than $16 billion in compensation for our clients, taking on huge corporations like Johnson & Johnson with extraordinary results.

Now we want to help you. In any way we can, with maximum compensation as our only goal.

Won’t Filing A Lawsuit Cost Me?

We want to help, not burden you with another problem. That’s why the Eliquis lawyers at Osborne & Associates offer their services on a contingency-fee basis: you owe us nothing until we win compensation for you.

Learning about your legal options comes at no charge, too. Just call our experienced lawyers at 877-515-4051 to schedule a free consultation today.

Call Now Button